Previous 10 | Next 10 |
2024-03-06 23:30:20 ET Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q4 2023 Earnings Call Mar 06, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call ...
2024-03-06 20:25:03 ET Inovio Pharmaceuticals, Inc. (INO) Q4 2023 Earnings Conference Call March 06, 2024 04:30 PM ET Company Participants Thomas Hong - Manager of Investor Relations Jacqueline Shea - President and Chief Executive Officer Michael Sumner - Chief M...
2024-03-06 16:12:10 ET More on Inovio Pharmaceuticals Inovio Pharmaceuticals, Inc. (INO) CEO Jacque Shea Presents at Oppenheimer 34th Annual Healthcare Life Sciences Conference Transcript Inovio: Planning A BLA To Reverse Its Long Path Of Misfortunes Inovio Pharmaceu...
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights PR Newswire Announced substantial progress with lead program, INO-3107, as potential treatment for Recurrent Respiratory Papillomatosis (RRP) Positive data announced from Pha...
Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting PR Newswire PHILADELPHIA , March 6, 2024 /PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company fo...
Klepierre (KLPEF) is expected to report for Q4 2023 comScore Inc. (SCOR) is expected to report $0.8 for Q4 2023 Universal Stainless & Alloy Products Inc. (USAP) is expected to report for Q4 2023 FAT Brands Inc. (FAT) is expected to report $-1.55 for Q4 2023 Jet.AI Inc. (JTAI) ...
2024-03-05 17:35:47 ET Major earnings expected after the bell on Wednesday include: Inovio Pharmaceuticals ( INO ) TriplePoint Venture Growth BDC Corp. ( TPVG ) Curaleaf Holdings ( OTCPK:CURLF ) Vermilion Energy ( VET ) Hudson Technologies ( HDSN ) ...
2024-02-26 17:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Q4 2023 revenue of $42.8 million Q4 2023 Adjusted EBITDA of $4.1 million Fourth consecutive quarter of positive Adjusted EBITDA with $16.7 million in positive Adjusted EBITDA in 2023 Philip Brace appointed Executive Chairman Inseego Corp. (Nasdaq: INSG) (the ...
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024 PR Newswire PLYMOUTH MEETING, Pa. , Feb. 21, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to hel...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
2024-07-16 13:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises and SMBs, today announced that the company will release its financial results for the second quarter of 2024, ended June 30, 2024, after the financial ...
INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway PR Newswire Award recognizes the potential for INO-3107 to be the first therapeutic option in the United Kingdom for patients suffering from Recurrent Respi...